Oncorus, Inc.
(NASDAQ : ONCR)

( )
ONCR After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen, Inc. -0.16%285.941.5%$893.22m
MRNAModerna, Inc. 3.17%181.480.0%$781.65m
GILDGilead Sciences, Inc. 0.08%87.901.0%$714.72m
REGNRegeneron Pharmaceuticals, Inc. 1.27%761.242.6%$526.50m
VRTXVertex Pharmaceuticals, Inc. 1.38%320.761.9%$498.80m
BIIBBiogen, Inc. -1.09%301.851.8%$409.62m
ILMNIllumina, Inc. 1.28%220.863.2%$264.16m
BNTXBioNTech SE 1.47%169.470.0%$176.40m
BMRNBioMarin Pharmaceutical, Inc. 2.02%103.024.2%$165.66m
SNSSSunesis Pharmaceuticals, Inc. -3.02%2.250.7%$157.28m
AXSMAxsome Therapeutics, Inc. -0.44%71.971.6%$142.81m
MRTXMirati Therapeutics, Inc. 0.13%91.501.6%$136.39m
NVAXNovavax, Inc. 2.18%16.8575.3%$77.01m
HALOHalozyme Therapeutics, Inc. 0.24%57.4018.4%$76.37m
TXG10X Genomics, Inc. 2.35%39.570.0%$58.25m

Company Profile

Oncorus, Inc. engages in the research and development of a viral immunotherapy platform. It develops an immunotherapy platform to treat cancer such as oncolytic Herpes Simplex Virus Platform and Synthetic Virus Platform. The company was founded by Mitchell H. Finer, Joseph C. Glorioso III, Kenneth P. Greenberg, Cyrus D. Mozayeni, and Paola Grandi on April 1, 2015 and is headquartered in Andover, MA.